438
Participants
Start Date
November 1, 2010
Primary Completion Date
January 1, 2012
Study Completion Date
February 1, 2012
Placebo
Matching placebo administered orally twice daily
Setipiprant
ACT-129968 (Dose 1, Dose 2, or Dose 3) administered orally twice daily
Clinical Investigative Site 5310, Budapest
Clinical Investigative Site # 5101, Sofia
Clinical Investigative Site # 5104, Sofia
Clinical Investigative Site 5906, Johannesburg
Clinical Investigative Site 5002, Glebe
Clinical Investigative Site 5304, Miskolc
Clinical Investigative Site 5309, Sátoraljaújhely
Clinical Investigative Site 5901, Durban
Clinical Investigative Site 5001, Sherwood
Clinical Investigative Site # 5303, Nyíregyháza
Clinical Investigative Site # 5102, Stara Zagora
Clinical Investigative Site 5003, Nedlands
Clinical Investigative Site 5910, Port Elizabeth
Clinical Investigative Site 5909, George
Clinical Investigative Site # 5103, Rousse
Clinical Investigative Site 5905, Cape Town
Clinical Ivestigative Site 5902, Cape Town
Clinical Investigative Site 5301, Siófok
Clinical Investigative Site 5307, Csorna
Clinical Investigative Site 5908, Bloemfontein
Clinical Investigative Site # 5308, Sopron
Clinical Investigative Site 6205, The Bronx
Clinical Investigative Site 5208, Berlin
Clinical Investigative Site 5701, Belgrade
Clinical Investigative Site 5702, Belgrade
Clinical Investigative Site 5212, Berlin
Clinical Investigative Site 5202, Rüdersdorf
Clinical Investigative Site 6203, Philadelphia
Clinical Investigative Site 5211, Hamburg
Clinical Investigative Site 6052, Lund
Clinical Investigative 5209, Lübeck
Clinical Investigative Site # 6223, Winston-Salem
Clinical Investigative Site 6230, Spartanburg
Clinical Investigative Site # 6228, Greenville
Clinical Investigative Site # 6219, Tallahassee
Clinical Investigative Site 5401, Haifa
Clinical Investigative Site 6108, Poltava
Clinical Investigative Site 6226, Nashville
Clinical Investigative Site 6202, Knoxville
Clinical Investigative Site 5205, Dortmund
Clinical Investigative Site 5405, Petach Tikvah
Clinical Investigative Site # 6217, Madison
Clinical Investigative Site 5204, Mainz
Clinical Investigative Site 6003, Linköping
Clinical Investigative Site 6110, Kharkiv
Clinical Investigative Site # 6101, Kharkiv
Clinical Investigative Site 6213, Normal
Clinical Investigative Site # 6209, St Louis
Clinical Investigative Site 5207, Gelnhausen
Clinical Investigative Site # 5404, Tel Aviv
Clinical Investigative Site # 5406, Tel Aviv
Clinical Ivestigative Site 6111, Odesa
Clinical Investigative Site 6105, Zaporizhia
Clinical Investigative Site # 6106, Zaporizhia
Clinical Investigative Site # 6215, New Orleans
Clinical Investigative Site # 5403, Rehovot
Clinical Investigative Site # 6225, Fort Worth
Clinical Investigative Site # 6222, San Antonio
Clinical Investigative Site 6229, San Antonio
Clinical Investigative Site # 5407, Ashkelon
Clinical Investigative Site # 6220, El Paso
Clinical Investigative Site # 6104, Donetsk
Clinical Investigative Site # 6006, Härnösand
Clinical Investigative Site # 6107, Uzhhorod
Clinical Investigative Site # 6204, Los Angeles
Clinical Investigative Site 6208, Los Angeles
Clinical Investigative Site # 5402, Jerusalem
Clinical Inverstigative Site #6201, Lake Oswego
Clinical Investigative Site # 6214, Portland
Clinical Investigative Site # 6002, Luleå
Clinical Investigative Site # 6207, Medford
Clinical Investigative Site 5602, Moscow
Clinical Investigative Site 5654, Moscow
Clinical Investigative Site 5607, Moscow
Clinical Investigative Site 5605, Saint Petersburg
Clinical Investigative Site 5604, Saint Petersburg
Clinical Investigative Site 5603, Kazan'
Clinical Investigative Site 5802, Singapore
Clinical Investigative Site 5609, Novosibirsk
Clinical Investigative Site 5608, Tomsk
Clinical Investigative Site 5610, Barnaul
Clinical Investigative Site 5606, Barnaul
Clinical Investigative Site # 6211, North Dartmouth
Clinical Investigative Site # 5305, Szombathely
Clinical Investigative Site 5302, Tatabánya
Clinical Investigative Site # 5507, Bialystok
Clinical Investigative Site # 5505, Krakow
Clinical Investigative Site # 5501, Lodz
Clinical Investigative Site # 5502, Lublin
Clinical Investigative Site # 5503, Tarnów
Clinical Investigative Site 5903, Pretoria
Clinical Investigative Site 5907, Pretoria
Clinical Investigative Site 6001, Gothenburg
Clinical Investigative Site 6007, Stockholm
Clinical Investigative Site 6004, Varberg
Clinical Investigative Site # 6102, Kyiv
Clinical Investigative Site # 6103, Kyiv
Lead Sponsor
Idorsia Pharmaceuticals Ltd.
INDUSTRY